Serodus ASA is a private Scandinavian drug development company that focuses on developing innovative treatments for diabetes and its related conditions. Operating as a virtual organization, Serodus in-licenses promising drug candidates in the early stages and manages the clinical development process through a network of contract organizations. With a management team that combines extensive experience in Big Pharma and BioPharm decision-making, Serodus has the expertise to drive drug candidates through clinical phase II.

Once positive clinical outcomes are established, the company seeks partnerships with international pharmaceutical companies. Serodus also actively identifies new drug candidates that address significant unmet clinical needs within the diabetic area and has a strong commitment to expanding its product portfolio through in-licensing promising drug candidates. With a focus on utilizing its expertise and proprietary know-how, Serodus aims to make a meaningful impact on patients' lives and establish lucrative partnering agreements for its products